Allan E. Karlsen
Steno Diabetes Center
Gentofte
Denmark
Name/email consistency: high
- Immune-mediated beta-cell destruction in vitro and in vivo-A pivotal role for galectin-3. Karlsen, A.E., Størling, Z.M., Sparre, T., Larsen, M.R., Mahmood, A., Størling, J., Roepstorff, P., Wrzesinski, K., Larsen, P.M., Fey, S., Nielsen, K., Heding, P., Ricordi, C., Johannesen, J., Kristiansen, O.P., Christensen, U.B., Kockum, I., Luthman, H., Nerup, J., Pociot, F. Biochem. Biophys. Res. Commun. (2006)
- Suppressor of cytokine signalling (SOCS)-3 protects beta cells against IL-1beta-mediated toxicity through inhibition of multiple nuclear factor-kappaB-regulated proapoptotic pathways. Karlsen, A.E., Heding, P.E., Frobøse, H., Rønn, S.G., Kruhøffer, M., Orntoft, T.F., Darville, M., Eizirik, D.L., Pociot, F., Nerup, J., Mandrup-Poulsen, T., Billestrup, N. Diabetologia (2004)
- Suppressor of cytokine signaling 3 (SOCS-3) protects beta -cells against interleukin-1beta - and interferon-gamma -mediated toxicity. Karlsen, A.E., Rønn, S.G., Lindberg, K., Johannesen, J., Galsgaard, E.D., Pociot, F., Nielsen, J.H., Mandrup-Poulsen, T., Nerup, J., Billestrup, N. Proc. Natl. Acad. Sci. U.S.A. (2001)